Learn about RITUXAN® (rituximab) treatment for rheumatoid arthritis (RA) patients including efficacy, safety, MOA and dosing. Please see Important Safety Information including Boxed Warning and Full Prescribing Information for more information.
RITUXAN®(rituximab) is a prescription medicine used to treat: Adults with Non-Hodgkin’s Lymphoma (NHL): alone or with other chemotherapy medicines. Children 6 months of age and older with mature B-cell Non-Hodgkin’s Lymphoma (NHL) and mature B-cell acute leukemia (B-AL): in combinati...
利妥昔单抗(Rituxan)是一种针对血癌、自身免疫性疾病和炎症性疾病的处方药。其适应症广泛,包括滤泡性淋巴瘤(FL)、非霍奇金淋巴瘤(NHL)、弥漫性大B细胞淋巴瘤(DLBCL)等多种病症。此外,Rituxan还有一种含有透明质酸酶的剂型——RITUXAN HYCELA,特别适用于治疗复发或难治性的FL、未经治疗的DLBCL以及CLL的成人患者。
HCP info about RITUXAN® (rituximab) treatment for RA, NHL, CLL, GPA, MPA and PV including safety information, dosing, efficacy and support. Please see Important Safety Information including Boxed Warning and Full Prescribing Information for more infor
Use the resources below to learn more about treating your GPA or MPA with Rituxan. Hear From People Who Have Taken Rituxan By watching the videos below, you'll hear from real patients with granulomatosis with polyangiitis (GPA). Their stories will give you a sense of their challenges and of...
利妥昔单抗(Rituxan) 批准治疗特定类型的B细胞非霍奇金淋巴瘤和与其他药物联合使用治疗慢性淋巴细胞白血病(CLL)。 阿仑珠 …www.biotech.org.cn|基于326个网页 3. 妥珠单抗 曲妥珠单抗(Rituxan)和贝伐单抗(Avastin),第一位的依那西普年销售额已达到52.9 亿美元,第十位的阿达木单抗年销售额…blog.eastmoney.com...
The meaning of RITUXAN is —used for a preparation of rituximab.
利妥昔单抗(Rituxan)是一种用于治疗白血病的药物。它是一种单克隆抗体,通过靶向CD20抗原来抑制白血病细胞的生长和分裂。利妥昔单抗可以与白血病细胞表面的CD20抗原结合,激活免疫系统来攻击和杀死这些异常细胞。 利妥昔单抗已被证明在治疗多种类型的白血病中具有显著的疗效。它可以用于治疗非霍奇金淋巴瘤(NHL)和慢性淋巴...
Rituxan的严重副作用并不常见,但可能会发生。如果您有严重的副作用,请立即就医。严重的副作用及其症状可能包括: 在接受一定剂量的利妥昔单抗时或之后的输注反应。症状可能包括:皮疹、降低血压、呼吸困难、脸和嘴唇肿胀。 皮肤或粘膜(受粘液保护的组织内膜)发生严重反应,例如史蒂文斯-约翰逊综合症和中毒性表皮坏死溶解。
Learn about RITUXAN® (rituximab) for granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA) including efficacy, MoA, dosing and safety. Please see Important Safety Information including Boxed Warning and Full Prescribing Information